Macular holes stage 2 | Macular holes stage 3 | Macular holes stage 4 | |||||||
---|---|---|---|---|---|---|---|---|---|
Phako-PPV | PPV | P Value | Phako-PPV | PPV | P Value | Phako-PPV | PPV | P Value | |
Number of eyes (n) | 72 | 21 | 197 | 73 | 25 | 18 | |||
Women / men (n) | 52 / 20 | 13 / 8 | 0.524* | 127 / 70 | 39 / 34 | 0.129* | 14 / 11 | 11 / 7 | 0.982* |
Mean age in years for women (±SD) | 68.06 (±5.22) | 75.46 (±6.19) | <0.001† | 66.12 (±6.84) | 75.42 (±8.31) | <0.001† | 69.14 (±7.79) | 72.64 (±4.24) | 0.195† |
Mean age in years for men (±SD) | 68.50 (±7.57) | 71.87 (±6.66) | 0.281† | 69.17 (±6.93) | 75.03 (±6.18) | 0.007† | 66.45 (±13.74) | 72.43 (±7.39) | 0.309† |
Right eye / left eye (n) | 40 / 32 | 8 / 13 | 0.248* | 97 / 100 | 31/42 | 0.393* | 11 / 14 | 9 / 9 | 0.937* |
Mean follow-up in days (±SD) | 16.23 (±6.06) | 14.33 (±4.23) | 0.186† | 16.70 (±11.59) | 17.88 (±12.51) | 0.472† | 19.6 (±10.05) | 20.44 (±9.83) | 0.785† |
Macula hole closed / open (n) | 71 / 1 | 19 / 2 | 0.248* | 184 / 13 | 62/11 | 0.053* | 24 / 1 | 15 / 3 | 0.379* |
Retinopexy / no retinopexy (n) | 24 / 48 | 6 / 15 | 0.884* | 77 / 120 | 20 / 53 | 0.102* | 5 /20 | 3 / 15 | 0.904* |